Literature DB >> 1454321

Correlation between biochemical composition and fluorescein binding of deposits in Bruch's membrane.

D Pauleikhoff1, S Zuels, G S Sheraidah, J Marshall, A Wessing, A C Bird.   

Abstract

PURPOSE: The fluorescence of drusen during fluorescein angiography is believed to have important prognostic and pathogenetic implications in age-related maculopathy. It is believed that deposits containing predominantly neutral lipids would be hydrophobic, resulting in hypofluorescence on fluorescein angiography, while the presence of polar phospholipids would be indicated clinically by hyperfluorescence because of its hydrophilic properties. To identify the potential determinants of fluorescence of drusen and Bruch's membrane, a series of macular specimens from human donors older than 60 years of age was examined. No clinical information was available concerning any previous eye disease.
METHODS: In vitro fluorescein binding was recorded microscopically, and the presence of fibronectin was sought by immunohistochemistry. The results were correlated with the proportions of phospholipids to neutral lipids identified by histochemical and biochemical studies.
RESULTS: It was found that high content of neutral fats was associated with lack of both fluorescein binding and fibronectin, and, conversely, in those specimens with high proportions of phospholipids, fluorescein binding was strong and fibronectin was present.
CONCLUSIONS: These observations support the central hypothesis concerning biophysical changes in Bruch's membrane with age and the potential importance of fluorescein angiography in the characterization of Bruch's membrane deposits.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1454321     DOI: 10.1016/s0161-6420(92)31768-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  43 in total

1.  Drusen characterization with multimodal imaging.

Authors:  Richard F Spaide; Christine A Curcio
Journal:  Retina       Date:  2010-10       Impact factor: 4.256

2.  The APO(*)E3-Leiden mouse as an animal model for basal laminar deposit.

Authors:  M Kliffen; E Lutgens; M J Daemen; E D de Muinck; C M Mooy; P T de Jong
Journal:  Br J Ophthalmol       Date:  2000-12       Impact factor: 4.638

Review 3.  Therapeutic targets in age-related macular disease.

Authors:  Alan C Bird
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

4.  Clinically detectable drusen domains in fibulin-5-associated age-related macular degeneration (AMD) : Drusen subdomains in fibulin-5 AMD.

Authors:  Murat Kucukevcilioglu; Chetankumar B Patel; Edwin M Stone; Stephen R Russell
Journal:  Int Ophthalmol       Date:  2015-12-23       Impact factor: 2.031

Review 5.  Plasma apolipoproteins and risk for age related maculopathy.

Authors:  N Dashti; G McGwin; C Owsley; C A Curcio
Journal:  Br J Ophthalmol       Date:  2006-05-24       Impact factor: 4.638

6.  Prevalence and morphology of druse types in the macula and periphery of eyes with age-related maculopathy.

Authors:  Martin Rudolf; Mark E Clark; Melissa F Chimento; Chuan-Ming Li; Nancy E Medeiros; Christine A Curcio
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03       Impact factor: 4.799

7.  Choroidal neovascularisation in age-related macular disease.

Authors:  A C Bird
Journal:  Br J Ophthalmol       Date:  1993-10       Impact factor: 4.638

8.  IL-33 is induced by amyloid-β stimulation and regulates inflammatory cytokine production in retinal pigment epithelium cells.

Authors:  Xiao-Cui Liu; Xiao-Fei Liu; Cong-Xiang Jian; Chen-Jun Li; Shou-Zhi He
Journal:  Inflammation       Date:  2012-04       Impact factor: 4.092

9.  Multimodal morphological and functional characterization of Malattia Leventinese.

Authors:  Giuseppe Querques; Benjamin Guigui; Nicolas Leveziel; Lea Querques; Francesco Bandello; Eric H Souied
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-20       Impact factor: 3.117

10.  Assessment of multifocal electroretinogram abnormalities and their relation to morphologic characteristics in patients with large drusen.

Authors:  Christina Gerth; David Hauser; Peter B Delahunt; Lawrence S Morse; John S Werner
Journal:  Arch Ophthalmol       Date:  2003-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.